<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37311808</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jun</Month><Day>13</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Natural history of long-COVID in a nationwide, population cohort study.</ArticleTitle><Pagination><StartPage>3504</StartPage><MedlinePgn>3504</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3504</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-023-39193-y</ELocationID><Abstract><AbstractText>Previous studies on the natural history of long-COVID have been few and selective. Without comparison groups, disease progression cannot be differentiated from symptoms originating from other causes. The Long-COVID in Scotland Study (Long-CISS) is a Scotland-wide, general population cohort of adults who had laboratory-confirmed SARS-CoV-2 infection matched to PCR-negative adults. Serial, self-completed, online questionnaires collected information on pre-existing health conditions and current health six, 12 and 18 months after index test. Of those with previous symptomatic infection, 35% reported persistent incomplete/no recovery, 12% improvement and 12% deterioration. At six and 12 months, one or more symptom was reported by 71.5% and 70.7% respectively of those previously infected, compared with 53.5% and 56.5% of those never infected. Altered taste, smell and confusion improved over time compared to the never infected group and adjusted for confounders. Conversely, late onset dry and productive cough, and hearing problems were more likely following SARS-CoV-2 infection.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hastie</LastName><ForeName>Claire E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>School of Health and Wellbeing, University of Glasgow G12 8TB, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lowe</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><Identifier Source="ORCID">0000-0003-4866-2049</Identifier><AffiliationInfo><Affiliation>School of Health and Wellbeing, University of Glasgow G12 8TB, Glasgow, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emergency Department, Queen Elizabeth University Hospital, Glasgow, G52 4TF, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McAuley</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Public Health Scotland, Meridian Court, Glasgow, G2 6QQ, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, G4 0BA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>Nicholas L</ForeName><Initials>NL</Initials><Identifier Source="ORCID">0000-0003-0533-7991</Identifier><AffiliationInfo><Affiliation>BHF Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, EH16 4SU, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Usher Institute, University of Edinburgh, Edinburgh, EH16 4UX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winter</LastName><ForeName>Andrew J</ForeName><Initials>AJ</Initials><Identifier Source="ORCID">0000-0002-8293-9462</Identifier><AffiliationInfo><Affiliation>Sandyford Sexual Health Services, NHS Greater Glasgow and Clyde, Glasgow, G3 7NB, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Corri</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Aberdeen Centre for Health Data Science, University of Aberdeen AB25 2ZD, Aberdeen, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Public Health Directorate, NHS Grampian, AB15 6RE, Aberdeen, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scott</LastName><ForeName>Janet T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, G61 1QH, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Donnell</LastName><ForeName>Catherine A</ForeName><Initials>CA</Initials><Identifier Source="ORCID">0000-0002-5368-3779</Identifier><AffiliationInfo><Affiliation>School of Health and Wellbeing, University of Glasgow G12 8TB, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blane</LastName><ForeName>David N</ForeName><Initials>DN</Initials><Identifier Source="ORCID">0000-0002-3872-3621</Identifier><AffiliationInfo><Affiliation>School of Health and Wellbeing, University of Glasgow G12 8TB, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Browne</LastName><ForeName>Susan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Health and Wellbeing, University of Glasgow G12 8TB, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ibbotson</LastName><ForeName>Tracy R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>School of Health and Wellbeing, University of Glasgow G12 8TB, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pell</LastName><ForeName>Jill P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0002-8898-7035</Identifier><AffiliationInfo><Affiliation>School of Health and Wellbeing, University of Glasgow G12 8TB, Glasgow, UK. Jill.pell@glasgow.ac.uk.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>COV/LTE/20/06</GrantID><Acronym>CSO_</Acronym><Agency>Chief Scientist Office</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MC_UU_00034/6</GrantID><Acronym>MRC_</Acronym><Agency>Medical Research Council</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003638" MajorTopicYN="Y">Deafness</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>14</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>13</Day><Hour>23</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>6</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37311808</ArticleId><ArticleId IdType="pmc">PMC10263377</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-39193-y</ArticleId><ArticleId IdType="pii">10.1038/s41467-023-39193-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global Burden of Disease Long Covid Collaborators, Wulf Hanson S, et al. Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604&#x2013;1615. doi: 10.1001/jama.2022.18931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11:269. doi: 10.3390/pathogens11020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, et al. Characterising long COVID: a living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat. Med. 2022;28:1706&#x2013;14. doi: 10.1038/s41591-022-01909-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat. Commun. 2022;13:3528. doi: 10.1038/s41467-022-30836-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-30836-0</ArticleId><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel SAM, Olde Hartman TC, Lucassen P, van Jaarsveld CHM. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam. Pract. 2022;39:159&#x2013;67. doi: 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M, et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat. Commun. 2022;13:1957. doi: 10.1038/s41467-022-29521-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-29521-z</ArticleId><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Ballering AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM. Lifelines Corona Research I. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet. 2022;400:452&#x2013;61. doi: 10.1016/S0140-6736(22)01214-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01214-4</ArticleId><ArticleId IdType="pmc">PMC9352274</ArticleId><ArticleId IdType="pubmed">35934007</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Ailshire JA, Crimmins EM. Long COVID and symptom trajectory in a representative sample of Americans in the first year of the pandemic. Sci. Rep. 2022;12:11647. doi: 10.1038/s41598-022-15727-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15727-0</ArticleId><ArticleId IdType="pmc">PMC9264749</ArticleId><ArticleId IdType="pubmed">35804058</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398:747&#x2013;58. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Brien K, et al. 1-year quality of life and health-outcomes in patients hospitalised with COVID-19: a longitudinal cohort study. Respir. Res. 2022;23:115. doi: 10.1186/s12931-022-02032-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-022-02032-7</ArticleId><ArticleId IdType="pmc">PMC9067558</ArticleId><ArticleId IdType="pubmed">35509060</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, et al. Twelve-month systemic consequences of coronavirus disease 2019 (COVID-19) in patients discharged from hospital: a prospective cohort study in Wuhan, China. Clin. Infect. Dis. 2021;74:1953&#x2013;1965. doi: 10.1093/cid/ciab703.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab703</ArticleId><ArticleId IdType="pmc">PMC9187317</ArticleId><ArticleId IdType="pubmed">34390330</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, et al. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir. Med. 2022;10:761&#x2013;775. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YH, et al. One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study. JAMA Neurol. 2022;79:509&#x2013;517. doi: 10.1001/jamaneurol.2022.0461.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.0461</ArticleId><ArticleId IdType="pmc">PMC8905512</ArticleId><ArticleId IdType="pubmed">35258587</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Bowe B, Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnusdottir I, et al. Acute COVID-19 severity and mental health morbidity trajectories in patient populations of six nations: an observational study. Lancet Public Health. 2022;7:e406&#x2013;e416. doi: 10.1016/S2468-2667(22)00042-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(22)00042-1</ArticleId><ArticleId IdType="pmc">PMC8920517</ArticleId><ArticleId IdType="pubmed">35298894</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin. Infect. Dis. 2021;74:1191&#x2013;1198. doi: 10.1093/cid/ciab611.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab611</ArticleId><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, et al. Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. 2021;18:e1003773. doi: 10.1371/journal.pmed.1003773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003773</ArticleId><ArticleId IdType="pmc">PMC8478214</ArticleId><ArticleId IdType="pubmed">34582441</ArticleId></ArticleIdList></Reference><Reference><Citation>Hastie CE, et al. Outcomes among confirmed cases and a matched comparison group in the Long-COVID in Scotland study. Nat. Commun. 2022;13:5663. doi: 10.1038/s41467-022-33415-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33415-5</ArticleId><ArticleId IdType="pmc">PMC9556711</ArticleId><ArticleId IdType="pubmed">36224173</ArticleId></ArticleIdList></Reference><Reference><Citation>So M, Kabata H, Fukunaga K, Takagi H, Kuno T. Radiological and functional lung sequelae of COVID-19: a systematic review and meta-analysis. BMC Pulm. Med. 2021;21:97. doi: 10.1186/s12890-021-01463-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-021-01463-0</ArticleId><ArticleId IdType="pmc">PMC7983097</ArticleId><ArticleId IdType="pubmed">33752639</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng X, Wang J, Sun J, Zhu K. COVID-19 and sudden sensorineural hearing loss: a systematic review. Front. Neurol. 2022;13:883749. doi: 10.3389/fneur.2022.883749.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.883749</ArticleId><ArticleId IdType="pmc">PMC9096262</ArticleId><ArticleId IdType="pubmed">35572936</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong M, et al. Direct SARS-CoV-2 infection of the human inner ear may underlie COVID-19-associated audiovestibular dysfunction. Commun. Med. 2021;1:44. doi: 10.1038/s43856-021-00044-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43856-021-00044-w</ArticleId><ArticleId IdType="pmc">PMC8633908</ArticleId><ArticleId IdType="pubmed">34870285</ArticleId></ArticleIdList></Reference><Reference><Citation>Fancello V, et al. SARS-CoV-2 (COVID-19) and audio-vestibular disorders. Int. J. Immunopathol. Pharmacol. 2021;35:20587384211027373. doi: 10.1177/20587384211027373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20587384211027373</ArticleId><ArticleId IdType="pmc">PMC8216371</ArticleId><ArticleId IdType="pubmed">34142589</ArticleId></ArticleIdList></Reference><Reference><Citation>Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107:234&#x2013;256. doi: 10.1016/j.neuron.2020.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.06.002</ArticleId><ArticleId IdType="pmc">PMC7381373</ArticleId><ArticleId IdType="pubmed">32553197</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiecolt-Glaser JK, Glaser R. Depression and immune function: central pathways to morbidity and mortality. J. Psychosom. Res. 2002;53:873&#x2013;876. doi: 10.1016/S0022-3999(02)00309-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3999(02)00309-4</ArticleId><ArticleId IdType="pubmed">12377296</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CH, Giuliani F. The role of inflammation in depression and fatigue. Front. Immunol. 2019;10:1696. doi: 10.3389/fimmu.2019.01696.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01696</ArticleId><ArticleId IdType="pmc">PMC6658985</ArticleId><ArticleId IdType="pubmed">31379879</ArticleId></ArticleIdList></Reference><Reference><Citation>Drevets WC, Wittenberg GM, Bullmore ET, Manji HK. Immune targets for therapeutic development in depression: towards precision medicine. Nat. Rev. Drug. Discov. 2022;21:224&#x2013;244. doi: 10.1038/s41573-021-00368-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-021-00368-1</ArticleId><ArticleId IdType="pmc">PMC8763135</ArticleId><ArticleId IdType="pubmed">35039676</ArticleId></ArticleIdList></Reference><Reference><Citation>Segerstrom SC, Miller GE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol. Bull. 2004;130:601&#x2013;630. doi: 10.1037/0033-2909.130.4.601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0033-2909.130.4.601</ArticleId><ArticleId IdType="pmc">PMC1361287</ArticleId><ArticleId IdType="pubmed">15250815</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller GE, Chen E. The biological residue of childhood poverty. Child Dev. Perspect. 2013;7:67&#x2013;73. doi: 10.1111/cdep.12021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cdep.12021</ArticleId><ArticleId IdType="pmc">PMC3766848</ArticleId><ArticleId IdType="pubmed">24032051</ArticleId></ArticleIdList></Reference><Reference><Citation>Sapolsky R. Sick of poverty. Sci. Am. 2005;293:92&#x2013;99. doi: 10.1038/scientificamerican1205-92.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/scientificamerican1205-92</ArticleId><ArticleId IdType="pubmed">16323696</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, et al. What is the recovery rate and risk of long-term consequences following a diagnosis of COVID-19? A harmonised, global longitudinal observational study protocol. BMJ Open. 2021;11:e043887. doi: 10.1136/bmjopen-2020-043887.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-043887</ArticleId><ArticleId IdType="pmc">PMC7948153</ArticleId><ArticleId IdType="pubmed">33692181</ArticleId></ArticleIdList></Reference><Reference><Citation>Scottish Index of Multiple Deprivation 2020. https://www.gov.scot/collections/scottish-index-of-multiple-deprivation-2020/. (2022).</Citation></Reference><Reference><Citation>HDR UK Phenotype Library. https://phenotypes.healthdatagateway.org/. (2022).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>